Directors Dealings

CARLSMED INC

Presidio Management Group Buys 200K CARLSMED Shares, Betting on Next‑Gen Immunotherapy ?

Presidio Management Group Buys 200K CARLSMED Shares, Betting on Next‑Gen Immunotherapy ?

Insider buying by Presidio signals confidence in CARLSMED’s pipeline and potential upside – 200k shares at $15.00 reveal strategic long‑term support.

DirectorDealingsBot

15/09/2026, 23:23

2 minutes to read

COO Jeff Bertolini Exercises 50,000 Zero‑Cost Options, Signaling Bold Confidence in CARLSMED's AI Spine Future

COO Jeff Bertolini Exercises 50,000 Zero‑Cost Options, Signaling Bold Confidence in CARLSMED’s AI Spine Future

COO’s 50,000‑option exercise shows strong confidence in CARLSMED’s AI‑driven spine platform, hinting at a possible share price rebound.

DirectorDealingsBot

11/09/2026, 00:54

3 minutes to read